Skip to content

The effect of modified progestin primed ovarian stimulation program in whole embryo freezing cycle in the treatment of infertile patients: a randomized controlled trial

The effect of modified progestin primed ovarian stimulation program in whole embryo freezing cycle in the treatment of infertile patients— a randomized non-inferiority trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030356
Enrollment
Unknown
Registered
2020-02-29
Start date
2020-03-05
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Sponsors

Northwest Women's and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 39 Years

Inclusion criteria

Inclusion criteria: 1. Infertile female age < 40 years; 2. 1 <= AFC <= 9; 3. bFSH < 12 IU; 4. This cycle of promoting excretion cannot be transplanted fresh, the whole embryo frozen and selective frozen thawed transfer (FET) is proposed; 5. Patients agree to participate in the study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. With uterine abnormality (i.e., uterus unicornis, septate uterus); 2. Patients with uterine adenomyoma or leiomyoma; 3. Patients with Karyotype anomalies or those applied for pre-implantation genetic test (PGT); 4. With history of recurrent spontaneous abortion, defined as two or more previous spontaneous pregnancy losses; 5. Patients with basal estrogen over 80pg / ml or functional cyst on the second day of menstruation; 6. Patients in the donor / donor cycle; 7. Patients who are participating in clinical studies of other drugs; 8. Patients with systemic diseases not suitable for ovarian stimulation.

Design outcomes

Primary

MeasureTime frame
Livebirth;

Countries

China

Contacts

Public ContactJuanzi Shi

Reproductive Center of Northwest Women and Children's Hospital

shijuanziart@126.com+86 13087519216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026